Stock Analysis on Net
Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

Medtronic PLC, common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018
Current debt obligations 1.73 1.21 1.13 1.49 0.57 0.02 6.29 6.29 6.37 4.11 0.94 0.02 0.01 0.01 3.93 4.21 6.20 3.06 0.91 0.96 1.60 0.93 1.53 1.52 1.72
Accounts payable 2.55 2.68 2.19 2.41 2.47 2.93 2.35 2.36 2.42 2.50 2.16 2.09 2.03 2.26 1.87 1.98 1.83 2.20 2.10 2.16 2.09 2.18 1.92 1.98 1.99
Accrued compensation 1.98 2.64 2.39 1.95 1.87 2.14 2.13 1.85 1.97 2.33 2.34 2.11 2.07 2.67 2.57 2.22 1.93 2.31 2.06 1.95 1.65 2.44 2.02 1.89 1.53
Accrued income taxes 1.18 1.48 1.22 1.21 1.12 0.92 0.70 0.70 0.61 0.77 0.42 0.51 0.37 0.47 0.41 0.42 0.42 0.55 0.49 0.49 0.55 0.63 0.73 0.61 0.87
Other accrued expenses 4.02 3.98 3.84 3.66 3.94 3.94 3.86 4.32 4.25 3.90 3.86 3.78 3.98 3.73 4.11 3.74 3.55 3.30 3.86 3.42 3.45 3.26 3.77 3.61 4.04
Current liabilities 11.46% 11.99% 10.78% 10.72% 9.97% 9.95% 15.32% 15.51% 15.62% 13.62% 9.72% 8.50% 8.46% 9.14% 12.89% 12.59% 13.94% 11.43% 9.41% 8.97% 9.33% 9.45% 9.98% 9.60% 10.16%
Long-term debt 29.32 26.60 26.59 26.35 26.95 26.77 23.59 22.26 19.44 22.39 26.46 27.91 28.28 28.34 27.25 27.08 24.35 24.28 26.64 27.18 27.18 27.30 26.68 26.86 26.39
Accrued compensation and retirement benefits 1.23 1.22 1.15 1.13 1.20 1.20 1.17 1.12 1.23 1.22 1.49 1.64 1.66 1.67 2.10 2.11 2.09 2.11 1.72 1.73 1.80 1.84 1.48 1.48 1.57
Accrued income taxes 2.14 2.07 2.00 1.97 2.65 2.59 2.45 2.80 2.34 2.29 2.30 2.30 2.46 2.42 2.33 2.68 2.90 2.96 2.95 2.97 3.15 3.16 3.24 3.35 3.39
Deferred tax liabilities 0.55 0.57 0.68 0.76 0.76 0.78 0.79 0.93 1.00 0.97 1.05 1.12 1.15 1.10 1.27 1.30 1.31 1.29 1.38 1.51 1.47 1.42 1.53 1.50 1.50
Other liabilities 1.64 1.52 1.55 1.73 1.89 1.90 1.84 1.54 1.60 1.55 1.55 1.69 1.72 1.89 1.82 1.76 1.70 1.83 1.92 1.93 1.74 0.84 0.81 0.82 0.89
Noncurrent liabilities 34.88% 31.98% 31.98% 31.95% 33.45% 33.24% 29.84% 28.66% 25.60% 28.43% 32.86% 34.65% 35.26% 35.42% 34.76% 34.94% 32.35% 32.47% 34.62% 35.32% 35.34% 34.57% 33.74% 34.00% 33.75%
Total liabilities 46.34% 43.97% 42.76% 42.67% 43.41% 43.19% 45.17% 44.17% 41.23% 42.05% 42.58% 43.15% 43.72% 44.56% 47.64% 47.53% 46.28% 43.90% 44.03% 44.30% 44.67% 44.02% 43.72% 43.60% 43.90%
Ordinary shares, par value $0.0001 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 23.19 25.70 27.07 27.28 27.09 27.04 26.04 26.21 27.06 27.00 28.12 28.40 28.52 28.27 27.41 27.62 27.97 28.85 28.17 28.74 29.00 29.58 29.89 30.68 31.00
Retained earnings 34.04 33.79 33.75 33.59 33.34 33.42 31.99 31.96 33.67 33.25 32.25 31.58 31.06 30.72 28.80 28.71 29.62 31.02 30.39 29.67 28.90 29.29 29.04 28.55 27.56
Accumulated other comprehensive loss -3.80 -3.69 -3.81 -3.75 -4.05 -3.85 -3.39 -2.53 -2.16 -2.49 -3.14 -3.32 -3.50 -3.74 -4.03 -4.01 -4.03 -3.93 -2.74 -2.87 -2.72 -3.02 -2.77 -2.96 -2.59
Shareholders’ equity 53.42% 55.81% 57.02% 57.12% 56.38% 56.61% 54.65% 55.64% 58.58% 57.76% 57.23% 56.66% 56.08% 55.25% 52.18% 52.32% 53.56% 55.95% 55.81% 55.55% 55.18% 55.85% 56.16% 56.28% 55.98%
Noncontrolling interests 0.24 0.23 0.22 0.21 0.21 0.20 0.19 0.19 0.19 0.19 0.19 0.18 0.19 0.19 0.17 0.16 0.16 0.15 0.16 0.15 0.15 0.13 0.13 0.12 0.12
Total equity 53.66% 56.03% 57.24% 57.33% 56.59% 56.81% 54.83% 55.83% 58.77% 57.95% 57.42% 56.85% 56.28% 55.44% 52.36% 52.47% 53.72% 56.10% 55.97% 55.70% 55.33% 55.98% 56.28% 56.40% 56.10%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31), 10-K (reporting date: 2020-04-24), 10-Q (reporting date: 2020-01-24), 10-Q (reporting date: 2019-10-25), 10-Q (reporting date: 2019-07-26), 10-K (reporting date: 2019-04-26), 10-Q (reporting date: 2019-01-25), 10-Q (reporting date: 2018-10-26), 10-Q (reporting date: 2018-07-27).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Medtronic PLC current liabilities as a percentage of total liabilities and equity increased from Q3 2024 to Q4 2024 but then slightly decreased from Q4 2024 to Q1 2025.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Medtronic PLC noncurrent liabilities as a percentage of total liabilities and equity decreased from Q3 2024 to Q4 2024 but then increased from Q4 2024 to Q1 2025 exceeding Q3 2024 level.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Medtronic PLC total liabilities as a percentage of total liabilities and equity increased from Q3 2024 to Q4 2024 and from Q4 2024 to Q1 2025.
Shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Medtronic PLC shareholders’ equity as a percentage of total liabilities and equity decreased from Q3 2024 to Q4 2024 and from Q4 2024 to Q1 2025.